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1  | INTRODUC TION
Coproduction is an approach which emphasizes collaboration 
between service providers and citizens The term was originally 
popularized by Ostrom1 and further developed by Cahn.2 Definitions 
of coproduction vary;3,4 however, most agree that it aims to promote 
the democratization of decisions made between citizens and service 
providers, working together to develop citizen- centred outcomes. 
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Abstract
Background: Coproduction is an approach increasingly recognized across public ser-
vices internationally. However, awareness of the term and the barriers and facilita-
tors to its implementation in the NHS are not widely understood. This study examines 
clinician and public perceptions of coproduction within the context of the Prudent 
Healthcare initiative.
Objectives: To provide insights into how coproduction is viewed by clinicians and the 
public and identify perceived barriers and facilitators to its implementation.
Design: Using qualitative research methods, interviews were conducted with the 
public (n = 40) and clinicians (n = 40). Five focus groups were also conducted with the 
public (n = 45) and six focus groups with clinicians (n = 26). The COM- B model was 
used to analyse the data; key domains include Capability, Opportunity and Motivation.
Setting: This is an all- Wales study, involving six Health Boards, an NHS trust and 
community and patient groups.
Results: Key barriers relating to Capability include lack of awareness of the term co-
production and inadequate communication between clinicians and citizens. 
Opportunity- centred barriers include service and time constraints. Conversely, facili-
tators included utilizing partnerships with community organizations. Motivation- 
related barriers included preconceptions about patients’ limitations to coproduce.
Conclusions: There were broadly positive perceptions among participants regarding 
coproduction, despite initial unfamiliarity with the term. Despite study limitations 
including underrepresentation of employed public participants and junior doctors, 
our analysis may assist researchers and policymakers who are designing, implement-
ing and evaluating interventions to promote coproduction.
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The New Economics Foundation described coproduction as a 
“means of delivering public services in an equal and reciprocal rela-
tionship between professionals, people using services, their families 
and their neighbours.”5
It is recognized that coproduction requires citizens to play an ac-
tive role in their health care.6 Coproduction encourages citizens to 
participate as fully as possible at different levels and according to 
their needs and capacity.7 This includes citizens contributing to co-
production on an individual level, as well as in the design and deliv-
ery of services.8 However, lack of citizen coaching and opportunities 
to participate effectively can limit system- level coproduction and 
tends to constrain it as a means to engage in individual patient- level 
interactions.9
A	 more	 active	 and	 patient-	centred	 relationship	 between	 citi-
zens and health- care services has been increasingly championed by 
researchers and policymakers worldwide.10-12 Coproduction has in-
creasingly featured as a core approach in public sector initiatives in-
cluding examples cited by Co- Create in Canada;13 the Organisation for 
Economic Cooperation and Development (OCED);14 and the National 
Endowment	for	Science	Technology	and	Arts	(NESTA)15 in the United 
Kingdom. Within this movement, there has been a focus on copro-
duction within health strategies, including the Scottish Government’s 
Realistic Medicine,10 and across NHS England.16 In 2015, the Welsh 
Government’s Prudent Healthcare initiative outlined the need to en-
sure the sustainability of the NHS against a background of constrained 
funding	and	increasing	demand.	A	core	principle	of	Prudent	Healthcare	
was coproduction.
Although	 there	 has	 been	 policy	 energy	 invested	 in	 supporting	
health- care services in Wales to adopt coproduction through the 
Prudent Healthcare initiative, there has been no prior assessment 
of public and clinician understanding and attitudes to coproduction 
through this initiative. Indeed, it was of particular interest to explore 
the views from those who expressed scepticism towards its purpose. 
This study aimed to understand how coproduction is viewed through 
the lens of the Prudent Healthcare initiative and to provide insights into 
facilitators and barriers to its implementation that were perceived by 
clinicians and the public. The focus was on the definition by the Bevan 
Commission,17 which is the basis of the Prudent Healthcare principle:
Co- production refers to a way of working whereby 
decision makers and citizens, or service providers and 
users, work together to create and deliver services. 
This includes consideration of broader social, eco-
nomic and cultural issues to avoid unnecessary med-
ical and therapeutic interventions to resolve health 
care needs.  (Bevan Commission, 2015)17
2  | METHODS
Semi- structured interviews and focus groups were carried out 
with the public, patients and clinicians across Wales. The data 
were used to understand how coproduction was understood by 
clinicians and members of the public and how receptive they were 
to the concept, and also to identify barriers and facilitators to its 
implementation.
2.1 | Participants
Purposive sampling was used to ensure diversity in age, gender and 
geographical area. We devised a sampling strategy to capture per-
spectives from members of the public who had varying health- care 
experiences and access to services. We therefore included both men 
and women with long- term conditions who were likely to have on-
going contact with health services; people with recent experience 
of using emergency health services; and parents of young children. 
We also speculated that people from different socio- economic back-
grounds might adopt different perspectives on coproduction, so we 
ensured we had representation of men and women from areas of low 
and high socio- economic deprivation (determined by the Welsh Index 
of Multiple Deprivation).18 Public participants were divided into five 
subsamples:
1. Patients with long-term conditions
2. Patients who have recently accessed emergency care
3. Parents of young children
4. Members of the public from areas of high socio-economic 
deprivation
5. Members of the public from areas of low socio-economic 
deprivation.
For our clinician sample, our aim was to ensure representation from 
throughout Wales. The sample included participants from a variety 
of clinical backgrounds in the NHS including primary, secondary and 
emergency care settings and with varying grades and seniority.
2.2 | Recruitment
Public participants were recruited through community groups 
(eg parent and toddler and Communities First groups), as well as 
through	general	practice	surgeries.	All	participants	were	aged	over	
18	years.	A	member	of	the	research	team	contacted	various	com-
munity groups to discuss the project and negotiate an opportu-
nity to attend a session to provide information about the study to 
the group’s membership. Three GP practices from across Wales 
agreed to help identify patients with long- term conditions and 
patients who had recently experienced out- of- hours care. GPs in-
vited patients who fulfilled the criteria to discuss the study with a 
researcher.
We recruited clinicians through six Health Boards and an NHS 
trust in Wales. Potential participants were approached via health 
board or trust partners or via professional organizations such as the 
Royal College of Nursing. Snowball sampling was also used.
Five public and patient involvement (PPI) representatives were 
recruited to contribute to early study documents, aid recruitment, 
comment on findings and assist with dissemination to lay audiences.
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Interested potential participants were provided with an informa-
tion pack outlining the purpose of the study and what was requested 
of them. If they agreed to participate, a time and place was arranged 
for	an	interview	or	a	focus	group.	All	participants	provided	written	
consent before participation.
2.3 | Ethical approval
Ethical approval for the study was sought and granted (ref: 15/
YH/0545). NHS R&D approval was given for recruiting of clinicians 
and recruiting of patients in primary care settings.
2.4 | Data collection
Interviews typically were undertaken at the participants’ home or in 
community venues or, in the case of clinicians, at their place of work. 
Focus groups typically were undertaken in a community centre or on 
university or NHS premises. The interviews and focus groups were 
audio- recorded, with the permission of the participants, transcribed 
and anonymized.
Following the interview or focus group, the researchers also col-
lected some basic demographic data about the participants in order 
to fully describe the sample.
2.5 | Theoretical framework
Our study was guided by the Behaviour Change Wheel (BCW), a 
framework that enables the systematic development of interven-
tions for supporting behaviour change, in this case public and cli-
nicians’ attitudes to coproduction. The Behaviour Change Wheel 
is underpinned by the COM- B model which has three interacting 
conditions for behaviour change to occur: Capability (eg knowl-
edge, cognitive abilities), Opportunity (eg access, cultural norms) and 
Motivation (eg beliefs, values).19
2.6 | Data analysis
Using the COM- B model framework, data analysis was supported by 
the NVIVO software program. Data analysis followed a framework 
approach20 where data were reread and common ideas and patterns 
emerging from interviews and focus groups were identified and 
coded by one author (DHH), grouped into subthemes and further 
abstracted to form broad themes, using both deductive (researcher- 
driven) and inductive (response- based) methods. Following this, 
themes were reviewed, refined and classified using the components 
of the COM- B model19 in an iterative process with refinement from 
coauthors.
3  | RESULTS
Participants included 85 members of the public; 40 took part in face- 
to- face interviews and 45 in five focus groups (Table 1). Participants 
could belong to more than one sample category (eg parents of young 
children living in an area of low socio- economic deprivation), but the 
table describes the sample characteristics on the basis of which they 
were recruited.
Sixty- six clinicians were recruited throughout Wales: general 
practitioners (GPs), nurses, hospital doctors, midwives, a pharmacist, 
a dentist, paramedics and allied health professionals such physio-
therapists. Forty took part in face- to- face interviews, and 26 took 
part in six focus groups (Table 2).
TABLE  1 Public and patient participant characteristics
Participant characteristic
Number of 
participants (%)
Sample
Patients with long- term conditions 15 (18)
Patients who sought emergency care 16 (19)
Parents of young children 18 (21)
Public from areas high socio- economic 
deprivation
19 (22)
Public from affluent areas 17	(20)
Health board area of home residence
Aneurin	Bevan 20 (24)
Abertawe	Bro	Morgannwg 14 (16)
Betsi Cadwaladr 12 (14)
Cardiff & Vale 10 (12)
Cwm Taf 15 (18
Hywel Dda 12 (14)
Powys 2 (2)
Gender
Male 37	(44
Female 48 (56)
Age	group
18- 25 10 (12)
26- 35 18 (21)
36- 45 14 (16)
46- 55 13 (15)
56- 65 9 (11)
66-	75 15 (18)
75+ 6	(7)
Disability
No disability 47	(55)
Disability 36 (43)
Prefer not to say 2 (2)
Employment status
Carer 4 (5)
Employed 30 (35)
Retired 21 (25)
Unemployed 18 (21)
Volunteer 4 (5)
Missing data 8 (9)
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Results are presented in line with the COM- B model’s Capability, 
Opportunity and Motivation and include the barriers and facilitators 
of coproduction that participants identified within the context of 
Prudent Healthcare (Table 3).
3.1 | Capability
Participants recognized that the capability of each citizen to partici-
pate in coproduction varies. Overall physical health including mental 
health and psychological factors such as knowledge and health lit-
eracy, empowerment, self- efficacy and communication skills were 
highlighted as facilitators and barriers.
3.2 | Physical capabilities
While participants generally agreed that citizens should take a cer-
tain amount of shared responsibility over their own health, they 
also recognized that facilitators such as appropriate support were 
required for individuals to be able to fully participate: “I’m all for peo-
ple taking at least some responsibility for their own health, given the 
right or appropriate information” (public participant from an affluent 
area).
It was acknowledged that the physical inequalities can hinder 
people’s capacity to play an active role in their health and that co-
production may be too challenging for some. Poor health, especially 
mental health, was recognized as a significant barrier to effective 
coproduction. Some clinicians recognized that extra support and 
advocacy should be provided in such cases, to enable patients to 
contribute to their full capacity, no matter how limited that may be: 
“There’s always the danger that you could exclude people who don’t 
feel that they have a voice, either through physical or mental abili-
ties… what we need is far greater advocacy” (primary care clinician, 
GP).
Many participants perceived that age and educational back-
ground contributed to whether someone would be able and willing 
to participate in coproduction: “I think it’s probably the younger 
more educated but I think the older generation is still of that gen-
eration that the doctor knows best and whatever they tell me I will 
accept” (secondary care clinician, midwife). However, there was little 
evidence from the public participants that older people would not 
want to, or be able to, coproduce, but rather that the assumption 
itself is a barrier and may need to be challenged.
3.3 | Psychological capabilities
3.3.1 | Health literacy and knowledge
Relatively few public participants and only about a third of clinicians 
recalled any prior knowledge of the term coproduction. Some ex-
pressed scepticism, including referring to it as a “buzzword.” Despite 
this, participants were broadly supportive of the concept, once it 
had been explained to them: “I had to ask what co- production was 
and to me it was just something that made sense… It should have 
always been there” (patient with a long- term condition).
Participants from both clinician and public groups discussed co-
production mainly in relation to one- to- one interactions between 
clinicians and patients. However, some participants recognized that 
coproduction also involves citizens consciously contributing to the 
design and transformation of services. The term was interpreted in 
varying ways even after explanation. Confusion was expressed over 
what the concept actually meant: “It’s not very clear to me what the 
role of public and patients is in the whole thing” (secondary care 
clinician, allied health professional). Despite this, a number of clini-
cians claimed that core elements of coproduction have been long 
established within the NHS and provided examples of coproduction: 
TABLE  2 Clinician participant characteristics
Participant characteristic
Number of 
participants (%)
Service setting
Primary care 23 (35)
Secondary care 28 (42)
Emergency and out- of- hours care 15 (23)
Health board or trust
Aneurin	Bevan 8 (12)
Abertawe	Bro	Morgannwg 8 (12)
Betsi Cadwaladr 6 (9)
Cardiff & Vale 22 (33)
Cwm Taf 15 (23)
Hywel Dda 2 (3)
Welsh	Ambulance	Service	Trust 5 (8)
Gender
Male 27	(41)
Female 39 (59)
Professional background
Allied	health	professional 11 (16)
Dentist 1 (1.5)
GP 13 (20)
Hospital doctor 10 (15)
Midwife 3 (5)
Nurse 20 (30)
Paramedic 5 (8)
Pharmacist 2 (3)
Missing data 1 (1.5)
Years since qualification
Less	than	one	year 2 (3)
1- 2 y 2 (3)
3- 9 y 11 (16)
10- 14 ys 7	(11)
15+ 38 (58)
Missing data 6 (9)
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“Involving the patients as partners is very much centre to what we 
do” (primary care clinician, GP).
Clinicians and members of the public felt there was a need 
to establish a more informed citizenry by introducing health ed-
ucation into schools and at a wider community level, in order to 
facilitate	coproduction.	Likewise,	some	participants	also	recalled	
or suggested using community groups, NHS professionals and the 
media to help inform citizens about issues related to their health. 
Participants argued that patients who were better informed 
about health choices, treatments and health services were gen-
erally more autonomous and would experience better health out-
comes:	“A	well-	educated	group	of	patients	not	only	achieves	more	
through engagement and empowerment in their own health but 
they actually make better use of NHS resources because they’re 
accessing the right professionals about the right query” (second-
ary care clinician, pharmacist).
3.3.2 | Communication skills
Participants reflected that improved communication between pa-
tients and professionals was central to the successful enactment of 
coproduction.
Members of the public emphasized a need for clinicians to 
consider the patient’s individual needs and circumstances, as pa-
tient dissatisfaction and disengagement were often caused by in-
complete or inadequate communication. Some patients reported 
having requested information to be communicated in more acces-
sible formats: “With some of the jargon they’ve used, we’ve had it 
broken down to us, so now we’re not afraid to ask questions and 
they put it in layman’s terms so we can all understand” (public par-
ticipant from an area of higher socio- economic deprivation).
Being listened to by clinicians was equally important as receiv-
ing	 information,	 according	 to	 some	 participants:	 “Listening	 to	 the	
patients and definitely seeing what they want and then the patients 
maybe meeting up with GPs and working together about how they 
want it to be” (public participant from area of high socio- economic 
deprivation).
According	to	a	wide	range	of	participants,	clinicians	need	to	be	
trained appropriately to communicate with and empower patients 
through coproduction: “That is dependent on health professionals 
having been trained to practice like that to start with and patients 
being encouraged to not just do as they’re told” (patient who ac-
cessed emergency care). Ensuring that coproduction is part of the 
medical, nursing and allied health professionals’ curriculum to as-
similate it as part of professional culture was considered potentially 
beneficial.
3.3.3 | Empowerment and self- efficacy
Patient involvement was perceived by some participants as being 
central to service effectiveness: “I think patients are crucial to the 
development of services” (secondary care clinician, pharmacist). 
COM- B Theme Barriers Facilitators
Capability
Physical capabilities Poor physical and mental 
health
Support and advocacy
Age	(perceptions) Bespoke advice
Psychological capabilities Lack	of	Knowledge	of	
coproduction and how to 
apply it
Increased publicity, 
education and training 
for citizens and staff
Inadequate communication 
skills
Training in communication 
skills
Lack	of	patient	empowerment	
and self- efficacy
Working with multidisci-
plinary teams
Insufficient information and 
power sharing with patients
Change in cultural 
perceptions and 
practices
Opportunity
Physical opportunities Allocation	of	appointment	time Restructure time 
allocation in services
Social opportunities Socio- economic inequalities Partnerships with 
community groups
Motivation
Reflective motivation Negative experiences of 
inclusion
Positive experiences of 
inclusion
Automatic	motivation Preconceptions of patient or 
service limitations
Challenging preconcep-
tions about practice
TABLE  3 Results: barriers and 
facilitators to coproduction
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Among	participants	there	was	also	a	general	consensus	that	the	pub-
lic had the right to know about their health and make decisions, as 
equal partners. However, participants conveyed contrasting views 
regarding the extent to which this could, and should, be achieved in 
practice: “Treating people as intelligent adults in charge of their own 
treatment, their own destiny. I think it’s a positive thing but I think it 
might take a long time for that to really slowly get through” (parent).
Positive attitudes towards patient involvement was particularly 
evident among allied health professionals as well as clinicians who 
worked in multidisciplinary teams: “There’s a lot less ‘yes doctor 
I’ll do that’ you don’t hear that anymore… they have as important 
a voice as anyone in their decisions made about their healthcare” 
(secondary care clinician, physiotherapist).
Some clinicians also felt that despite their good intentions to 
equalize power within the relationship, ultimately the balance of 
power may lean towards the practitioner: “You can’t have equal 
partnerships where you’ve got an imbalance of power. In fairness we 
have the power. They’re coming to us to ask us for treatment, we get 
the last say in whether or not they get that” (primary care clinician, 
nurse, focus group). This view of patient involvement was echoed in 
the views of some members of the public who were more sceptical 
about its application: “Working alongside the patient to find together 
a shared solution, I’m not sure that happens very often actually and 
I’m not sure it’s the expectation of many patients” (public participant 
from area of high socio- economic deprivation).
Although	 the	 participants	 recognized	 the	 potential	 benefits	 of	
greater empowerment, they reported varying levels of self- efficacy. 
Some expressed concerns over of their capacity to be heard or to 
challenge the system, while others felt that some people would 
abuse the system “people will be kicking off and demanding to get 
treatment” (focus group public participant from an area of high 
socio- economic deprivation).
Apprehensions	about	power	imbalances	were	also	conveyed	by	
clinicians who felt increasing pressure to ensure patients are happy 
with what is offered to them: “Patients can be more demanding as a 
result and this can lead to wasted appointments as they demand to 
be seen more often” (primary care clinician, GP). Thus, participants’ 
highlighted tensions between patient empowerment and its practical 
delivery within an NHS that is struggling with resource constraints.
3.3.4 | Sharing information and decisions
Clinical and public participants largely felt that clinicians’ willingness 
to share and discuss information, including diagnoses and treatment 
choices, with patients was fundamental to successful coproduction. 
A	number	of	public	participants	recalled	positive	experiences	of	being	
involved in information sharing and decision making. Despite positive 
accounts, a reluctance on the part of some practitioners to share in-
formation was noted by other clinicians: “We still have a culture where 
some clinicians don’t feel that they can share the patient’s records with 
them and discuss their pathways of care, or if the patients have got a 
concern there’s still some trepidation about sharing clinical informa-
tion” (secondary care clinician, midwife).
It was acknowledged that patients do not always have the op-
portunity to participate in decision making, as ultimately, responsi-
bility for health care still rests with clinicians. Furthermore, clinicians 
acknowledged that not all practitioners practised patient- centred 
medicine.
3.4 | Opportunities
3.4.1 | Physical opportunities
The most significant service- based barrier to coproduction reported 
by participants was time limitation: “I think time is really key, we’re 
so pressurised for time seeing patients and the volume that want to 
be seen” (primary care clinician, GP).
Members of the public recognized that clinicians had to deal with 
competing priorities, as well as externally imposed targets which 
would reduce the time available to coproducing health care. One 
patient reflected on this service- level barrier from a clinician’s per-
ceptive: “It’s that I either spend the time that I would like with this 
patient and then I’m in trouble because I haven’t met my target, or I 
meet my target but then I’m not giving that person the service they 
deserve” (patient with long- term condition).
Due to what was perceived as being a time- intensive process, 
some participants expressed scepticism about the resource effec-
tiveness of coproduction. This emphasizes a need for further discus-
sions between the public and clinicians regarding the purpose and 
benefits of coproduction. Underlying financial and practical limita-
tions were perceived as impeding coproduction, as one parent ques-
tioned how patients’ requests are prioritized: “Does one person have 
the right to choose much more expensive treatment that enables 
them to do this and another person something else?” (parent).
3.4.2 | Social opportunities
Community- based support was perceived to be an intrinsic element 
of the delivery of coproduction. This was particularly applicable 
where citizens faced health and social inequalities, as health- based 
support groups and health advocates regularly acted as facilitators 
of coproduction. Some clinicians stated that they worked with local 
groups to provide bespoke patient- centred health- care provision 
within community settings: “If I go and run something in [community 
centre] no one will come, if you run it with the community group, with 
an interpreter, an advocate for that community, hundreds of people 
will turn up and they’re all really interested” (secondary care clinician, 
allied health professional). Utilizing preexisting networks and building 
relationships with community- based organizations were key to ena-
bling coproduction at a community level, especially among those who 
face greater levels of socio- economic deprivation or isolation.
3.5 | Motivation
Clinicians and members of the public highlighted the importance 
of reflective motivations when considering the extent to which 
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coproduction is achievable in practice. For some, active participa-
tion was a very positive experience: “Everyone loves taking part, es-
pecially in their own healthcare, they love feeling involved” (member 
of the public from area of high socio- economic deprivation). Others 
argued that certain patients would not want to be involved in health- 
care decisions: “I find that some patients you try and give them op-
tions, you try involve them in decision making and they don’t want to 
be involved” (primary care clinician, GP).
It was also perceived that automatic motivations such as assump-
tions or preconceptions from either party could prevent coproduc-
tion. Examples from clinicians included the following: “Patients come 
with preconceptions and it used to be the preconceptions from a 
grandmother, or an aunty… these days they come with preconcep-
tions they’ve picked up from the internet, from the media and that’s 
often fed by political agendas” (primary care clinician, GP).
There was also recognition that patient demands, fuelled by 
emotions combined with financial concerns, can complicate the 
implementation of coproduction: “You don’t want to be spending 
lots of money doing what the patient wants, if all the research 
and everything the doctor who has the knowledge is saying do 
something different… especially if you’re talking about emotive 
stuff” (member of the public from area of low socio- economic 
deprivation).
4  | DISCUSSION
4.1 | Principal findings
Coproduction has been described as a cornerstone of public policy 
reform21 and a potential vehicle through which to deliver effec-
tive public services in resource- lean economies. Using the COM- B 
model, a wide range of facilitators and barriers, seen to influence 
public and clinicians’ capability, opportunity and motivation to en-
gage in coproduction, was identified.
The most commonly reported barriers to coproduction were 
within the domain of Capability. This was in relation to awareness 
of the concept of coproduction, concerns about the limited abil-
ities of sections of society to be partners in coproducing health 
care and poor health literacy. Most participants were supportive 
of the concept of coproduction, once they were informed of its 
meaning, but awareness of coproduction as a guiding principle 
of the NHS in Wales was poor. Furthermore, when coproduction 
was discussed, it was usually in the form of patient involvement 
in decisions about their own care processes rather than involve-
ment in the planning, delivery and improvement of the service as 
a whole.
Opportunities to engage in coproduction were seen to be lim-
ited by clinicians’ time and the resources available to them. However, 
many spoke positively about the role that third- sector organizations, 
particularly health charities, can play in facilitating more informed 
and empowered citizens.
In terms of Motivation, some clinicians and public participants 
appeared to be expressing concerns about whether coproduction 
had the potential to improve health provision. This was expressed 
in terms of previous negative experiences of involvement (or of in-
volving	patients).	Likewise,	there	were	some	doubts	about	whether	
it was feasible or sustainable for citizens to be empowered as equal 
partners within the current system.
4.2 | Comparison with existing research
Our data confirm those of other studies, which illustrate that effec-
tive communication between practitioners and citizens can facilitate 
coproduction,6,22,23 particularly during consultations where patients 
and clinicians are engaged in shared decision making. Considerable 
work has already been conducted on the importance of heath lit-
eracy24 and patient empowerment25,26 as a means to move away 
from paternalistic styles to more equitable and collaborative styles 
of health- care delivery. The wide policy priority for patient- centred 
care and shared decision making27 has encouraged professionals and 
patients to examine new ways of enabling participation.
Other authors have highlighted the social and economic barri-
ers to coproduction,28-30 and these factors were also evident in our 
study. Conversely, the value of shared responsibility for outcomes 
is debatable and too much patient autonomy can result in poor out-
comes and inefficiency in the system.31 However, the health service 
cannot abandon patients who do not have the capacity or personal 
resources to partner effectively.
Our findings also reflect the work of previous studies which 
demonstrate that citizen activation can be enhanced by develop-
ing the role that community organizations play in facilitating more 
informed and empowered citizens.32 While in our study this was 
seen as a positive move and a facilitator to coproduction, con-
cerns have been expressed about the appropriation of a movement 
which may have genuinely started to give citizens and commu-
nity groups more control, but has since been conflated with dis-
courses of austerity and public service retrenchment.33 Finally, 
power sharing requires new forms of accountability and conceding 
of some professional control. Other authors have also noted that 
coproduction can bring with it a host of concerns such as compe-
tency and risks.34
4.3 | Implications for policy and practice
Coproduction is an increasingly popular concept, and while often 
unfamiliar to clinicians and the public, once explained it is found 
to be broadly acceptable. Despite this, there is a need for further 
guidance and support from health services, partner organizations 
and governments to encourage a shared understanding among 
staff and members of the public about what coproduction might 
mean in the context of health care. Implementing coproduction 
in the NHS will also require strengthening the capability of staff 
and citizens to share power and responsibility in relation to health. 
This might involve the enhancement of physical and social oppor-
tunities, including staff training and partnerships with third- sector 
organization.
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4.4 | Strengths and limitations
The COM- B model offered clear methods to identify barriers and 
facilitators to coproduction within the wider context of Prudent 
Healthcare. In this study, we incorporated the views of public par-
ticipants representing a variety of ages and socio- economic back-
grounds across Wales, although there is limited representation of 
employed public participants. Some clinical groups were also under-
represented, such as junior doctors, who could have added useful 
perspectives to the findings.
4.5 | Further research
Future research could evaluate the feasibility, acceptability and ef-
fectiveness of implementing interventions to promote coproduction 
within the NHS. Interventions might include staff and undergradu-
ate training and partnerships with third- sector organizations.
5  | CONCLUSIONS
Coproduction aims to improve the performance of existing public 
services by actively involving citizens in their design and evalua-
tion. Our study highlights the varying yet broadly positive percep-
tions among the public and clinicians to coproduction in relation to 
health services. Despite a general lack of awareness of the term, 
many participants felt that the key elements of coproduction have 
been accepted and used in parts of clinical practice. Health poli-
cies designed to produce a shift to a more coproduced model of 
health- care delivery should consider that actors (patients, health- 
care providers and the health- care system itself) will be constrained 
by some of the barriers identified in this study. These include lack 
of knowledge relating to how to conceptualize and undertake co-
production, attitudes of patients and clinicians towards power 
sharing and service- level barriers such as the allocation of time for 
appointments. Importantly, if coproduction is to become a reality 
in health care and these barriers are to be mitigated, then training 
for staff within the NHS and partnership organizations is required 
to promote opportunities for understanding and implementing 
coproduction.
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